# Immuneering Corporation (IMRX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/IMRX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -30.73M | $ -35.04M | $ 3.63M | $ 190.74M |
| 2025 | $ 0 | $ -57.36M | $ -46.57M | $ 3.82M | $ 218.48M |
| 2024 | $ 0 | $ -64.15M | $ -57.90M | $ 4.16M | $ 41.39M |
| 2023 | $ 0 | $ -57.82M | $ -53.32M | $ 4.46M | $ 90.58M |
| 2022 | $ 354.1K | $ -56.43M | $ -50.10M | $ 4.84M | $ 109.85M |
| 2021 | $ 2.47M | $ -39.86M | $ -36.74M | $ 5.36M | $ 155.98M |
| 2020 | $ 2.94M | $ -21.71M | $ -18.69M | $ 621.1K | $ -22.48M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.02 |
| Liabilities / Eq | 0.06 |
| Current Ratio | 19.47 |

## Other views

- [Metrics](https://sponda.capital/en/IMRX.md)
- [Charts](https://sponda.capital/en/IMRX/charts.md)
- [Compare](https://sponda.capital/en/IMRX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.